top of page


Backing, building and exiting: what the BioInvest Catalyst Dinner revealed about life sciences capital
On Wednesday 28 October, BioNSW members filled The Oriana for the BioInvest Catalyst Dinner, a candid evening with people who have backed, built and exited life sciences companies. The case study was Tetratherix (ASX: TTX). The Sydney medtech grew out of research at the University of Sydney and listed on the ASX in June 2025. It raised $25 million at $2.88 a share, valuing the company at $145 million. It was also a deliberate choice to raise less: CEO Will Knox cut the IPO fr
Nov 32 min read


BioInvest Catalyst Dinner: Turning Conversations into Capital
The latest instalment of BioNSW's BioInvest Catalyst Dinner series was held on 21 July 2026. The sell out dinner brought together life sciences leaders and investors at The Oriana Sydney, against the backdrop of Sydney Harbour Bridge and the Opera House, for an evening focused squarely on one goal: unlocking capital for the NSW biotech sector. As BioNSW Investment Committee Chair Christian Toouli reflected afterwards, “It was a fabulous event: an engaging format, a great venu
Jul 232 min read


Why R&D Tax Incentive and CGT Changes Could Cost the NSW Life Sciences Sector its Innovation Edge
A packed room at EY's Sydney office on July 7th 2026 put one point beyond doubt: the Life Sciences sector is not divided on the proposed RDTI and CGT changes, rather, it is aligned, and it is not staying quiet.BioNSW partnered with EY to host a Federal Budget Briefing on the proposed changes to the Research and Development Tax Incentive (RDTI) and Capital Gains Tax (CGT) settings. The turnout reflected how directly these settings touch the sector's ability to fund discovery,
Jul 143 min read


BioNSW Hold Successful Post-BIO Briefing
August saw BioNSW kick-off the Financial Year with a retrospective look at NSW's delegation to the 2024 BIO Conference. At an event...
Sep 2, 20243 min read


BioNSW Announces Post-BIO Briefing
⏰ We're excited to announce, in collaboration with Investment NSW and kindly hosted by King & Wood Mallesons, a Post-BIO Briefing event...
Jul 29, 20241 min read
bottom of page
